Predictors of Aortic Root Dilatation in Tetralogy of Fallot Patients

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06081855
Collaborator
(none)
77
16

Study Details

Study Description

Brief Summary

  • To predict vulnerable patients for aortic root dilatation in TOF patients using CT as a reliable imaging modality, thus aiding early intervention, and identifying those who will require strict follow-up.

  • To assess the prevalence of TOF patients who developed aortic root dilatation, and those who were complicated with dissection, AR, and aneurysm, through collecting data from a large center (Aswan Heart Centre).

  • To investigate the relationship between age at repair and the diameter of aortic root.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CT

Detailed Description

Tetralogy of Fallot (TOF) occurs in approximately 3 to 5 of every 10,000 live births and is the most common cyanotic congenital heart defect and it exhibits four main features. These features are pulmonary stenosis, right ventricular hypertrophy, overriding aorta and ventricular septal defect. Moreover, since the survival of patients with congenital heart diseases has improved significantly in recent decades, long-term complications should be monitored cautiously. One of these complications is aortic root dilatation, attributed to increased and altered flow through the overriding aorta and an uneven sharing of conotruncal tissue between the aorta and pulmonary artery, particularly in patients who have not undergone early repair.

Despite the concern that TOF patients may harbor aortopathy that can lead to aortic regurgitation, aortic aneurysms, and, potentially, aortic dissection, the scope of the problem remains uncertain. Prevalence estimates of aortic root dilatation have ranged from 15% to 87% with the use of various criteria. Moderate to severe aortic regurgitation (AR) has also been reported in up to 12.5% of adults with TOF and dilated aortic roots. The incidence of aortic dissection and surgical intervention remains unknown. Moreover, features associated with aortic dilatation are not fully understood. Therefore, correlating and predicting vulnerable patients and identifying possible risk factors for aortic root dilatation in TOF patients, will enable more cautious follow-up and earlier intervention, thus decreasing possible morbidity and mortality.

Study Design

Study Type:
Observational
Anticipated Enrollment :
77 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Predictors of Aortic Root Dilatation in Tetralogy of Fallot Patients
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Feb 28, 2025
Anticipated Study Completion Date :
May 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Repaired TOF

Diagnostic Test: CT
Measuring aortic root diameter by CT

Unrepaired TOF

Diagnostic Test: CT
Measuring aortic root diameter by CT

Outcome Measures

Primary Outcome Measures

  1. Aortic root diameters [Throughout the study duration, about 1 year]

    : Aortic root diameters at four levels: aortic annulus (AA) sinus of Valsalva (SoV) sinotubular junction (STJ) ascending aorta (AAo). AA will be measured as the inter-commissural distance in the aortic valve, SoV will be measured at the level of maximal diameter on the axial image, STJ will be measured at the level of transitional zone from STJ to AAo, and AAo will be measured at the level of the main pulmonary artery bifurcation. Aortic cross-sectional area will be calculated by π×(diameter/2)2 The largest diameters of each aortic structure as measured based on the chest CT will be re-calculated as z-scores. In our study, "significant dilatation of the aortic structures" is defined as 95% confidence interval (z-score≥2) in diameter of each aortic structures. Echocardiography will be performed to check other cardiac deformities, including AR.

Secondary Outcome Measures

  1. Aortic valve repair or surgical or transcatheter aortic valve replacement [Throughout the study duration, about 1 year]

  2. Severity of AR at latest follow-up or before the earliest aortic valve or root intervention. [Throughout the study duration, about 1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • All patients with TOF who either underwent or have not yet had surgical correction.

  • All patients with Fallot-type DORV.

  • Patients should have survived until discharge and have at least one echocardiography and CT with full data related to one or more anatomic subcomponents of the aortic root, either before surgery or during follow-up, regardless of specific duration post repair.

Exclusion Criteria:
  • Patients who have contraindication for conducting cardiac CT scan. For instance, dye sensitivity, pregnancy, CKD, in addition to patients who have factors that interfere with CT image quality as metallic objects within the chest (e.g. Pacemaker).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

  • Study Chair: Amr Elbadry, MD, Assiut University, Faculty of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Abdelrahman Gamal Ahmed Ramadan, Principle investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT06081855
Other Study ID Numbers:
  • Aortic Root Dilatation in TOF
First Posted:
Oct 13, 2023
Last Update Posted:
Oct 13, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2023